Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
3.
Cochrane Database Syst Rev ; (1): CD002243, 2004.
Article in English | MEDLINE | ID: mdl-14973984

ABSTRACT

BACKGROUND: Sepsis may be complicated by impaired corticosteroid production. Giving corticosteroids could potentially benefit patients. OBJECTIVES: To examine the effects of corticosteroids on death at one month in patients with severe sepsis and septic shock. SEARCH STRATEGY: We searched the Cochrane Infectious Diseases Group's trial register (August 2003), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 3, 2003), MEDLINE (August 2003), EMBASE (August 2003), LILACS (August 2003), reference lists of articles, and also contacted trial authors. SELECTION CRITERIA: Randomized and quasi-randomized controlled trials of corticosteroids versus placebo or supportive treatment in severe sepsis and septic shock. DATA COLLECTION AND ANALYSIS: Two pairs of reviewers agreed the eligibility of trials. One reviewer extracted data, which was checked by the other reviewers and the primary author of the paper whenever possible. We obtained some missing data from the trial authors. We assessed trial methodological quality. MAIN RESULTS: We identified 15 trials (n =2023). Corticosteroids did not change 28-day all-cause mortality (15 trials, n = 2022, relative risk (RR) 0.92, 95% confidence interval (CI) 0.75 to 1.14; random effects model) and hospital mortality (13 trials, n = 1418, RR 0.89, 95% CI 0.71 to 1.11; random effects model); however, there was statistically significant heterogeneity, with some evidence that this was related to the dosing strategy. Corticosteroids reduced intensive care unit mortality (4 trials, n = 425, RR 0.83, 95% CI 0.70 to 0.97), increased the proportion of shock reversal by day 7 (6 trials, n = 728, RR 1.22, 95% CI 1.06 to 1.40) and by day 28 (4 trials, n = 425, RR 1.26, 95% CI 1.04 to 1.52), without increasing the rate of gastroduodenal bleeding (10 trials, n = 1321, RR 1.16, 95% CI 0.82 to 1.65), superinfection (12 trials, n = 1705, RR 0.93, 95% CI 0.73 to 1.18), and of hyperglycaemia (6 trials, n = 608, RR 1.22, 0.84 to 1.78). REVIEWER'S CONCLUSIONS: Overall, corticosteroids did not change 28-day mortality and hospital mortality in severe sepsis and septic shock. Long course of low dose corticosteroids reduced 28-day all-cause mortality, and intensive care unit and hospital mortality.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Sepsis/drug therapy , Humans , Randomized Controlled Trials as Topic , Sepsis/mortality , Shock, Septic/drug therapy , Shock, Septic/mortality
6.
N Engl J Med ; 343(9): 660-1, 2000 Aug 31.
Article in English | MEDLINE | ID: mdl-10979804
8.
Gastroenterol Clin North Am ; 29(2): 275-307, v, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10836184

ABSTRACT

Gastrointestinal (GI) hemorrhage is a common and potentially lethal medical emergency that is a common cause for intensive care unit admission. The intensivist plays an important role as a member of the medical team managing the patient with GI bleeding who is at high risk because of severe bleeding, comorbidity, or the presence of endoscopic stigmata of recent hemorrhage. This article presents the intensivist's approach to GI hemorrhage in initial patient assessment, triage, resuscitation, specialist consultation, diagnostic evaluation, and medical therapy. This article focuses on types of GI bleeding of particular concern to the intensivist, including esophageal variceal bleeding, stress-related GI bleeding, and GI bleeding associated with myocardial infarcation.


Subject(s)
Gastrointestinal Hemorrhage , Intensive Care Units , Resuscitation/methods , Acute Disease , Blood Transfusion , Clinical Competence , Endoscopy, Gastrointestinal , Fluid Therapy , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/therapy , Humans , Practice Guidelines as Topic , Prognosis , Suction
12.
South Med J ; 89(11): 1095-6, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8903295

ABSTRACT

Gas gangrene is a life-threatening emergency. Most cases are caused by clostridial infections, but nonclostridial causes are being increasingly recognized. Nonclostridial gas gangrene is most often due to polymicrobial organisms. Early diagnosis and therapy are required, since the disease may rapidly progress to fatal toxemia. We report a case of gangrenous, atraumatic, nonclostridial myonecrosis of the arm due to Enterobacter cloacae in a nondiabetic patient with neutropenia.


Subject(s)
Arm , Enterobacter cloacae , Enterobacteriaceae Infections/microbiology , Gas Gangrene/microbiology , Immunocompromised Host , Pancytopenia/complications , Antineoplastic Agents/adverse effects , Enterobacteriaceae Infections/therapy , Fatal Outcome , Gas Gangrene/therapy , Humans , Male , Middle Aged , Pancytopenia/chemically induced , Pancytopenia/immunology
13.
Chest ; 109(5): 1408-9, 1996 May.
Article in English | MEDLINE | ID: mdl-8625702
16.
Arch Intern Med ; 150(2): 318-20, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2302007

ABSTRACT

Tracheal intubation is a commonly performed procedure generally associated with a low complication rate. A clinical sign that could lead to early detection of complications could improve management of mechanically ventilated patients. We present two instances of potentially lethal complications that were heralded by the presence of massive gastric distention. This finding should alert physicians that an abnormal communication may exist between the endotracheal tube and the gastrointestinal tract.


Subject(s)
Esophagus , Intubation, Intratracheal/adverse effects , Stomach , Tracheoesophageal Fistula/etiology , Aged , Dilatation, Pathologic/etiology , Female , Humans , Radiography , Stomach/diagnostic imaging , Stomach/pathology
SELECTION OF CITATIONS
SEARCH DETAIL